Hanwen Zhang
7PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 29, 2024
VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer.Tenzin Passang, Shuhua Wang, Hanwen Zhang
|May 10, 2024
Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma Cells to TRAIL-Mediated Apoptosis.Yuki Kuranaga, Bing Yu, Satoru Osuka
|Jul 28, 2023
Administration of AG490 decreases the senescence of umbilical cord-mesenchymal stem cells and promotes the cytotherapeutic effect in liver fibrosis.Chenhao Jiang, Huaxin Chen, Yinqian Kang
|Oct 27, 2022
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.Sruthi Ravindranathan, Tenzin Passang, Jian-Ming Li
|Apr 20, 2022
Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression.Jingru Zhu, Yitong Wang, Jingxia Li
|Nov 03, 2019
Correction: EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.Hanwen Zhang, Dan Zhu, Zhaobin Zhang
Pageof 2
Frequent Collaborators
3 joint publications
Erwin G Van Meir
3 joint publications
Sruthi Ravindranathan
3 joint publications
Edmund K Waller
2 joint publications
Tenzin Passang
2 joint publications
Jian-Ming Li
2 joint publications
Yuan Liu
2 joint publications
Gregory B Lesinski
1 joint publications
Jingru Zhu
1 joint publications
Jingxia Li
1 joint publications
Rohan Dhamsania
